Susanne Beckebaum

Articles in Scholarly Journals [Incomplete List]

  1. Predictors of Graft and Patient Survival in Hepatitis C Virus (HCV) Recipients: Model to Predict HCV Cirrhosis After Liver Transplantation
    Transplantation, vol. 84, no. 1, pp. 56–63, 2007
  2. De Novo Hepatocellular Carcinoma in Recurrent Liver Cirrhosis After Liver Transplantation for Benign Hepatic Disease: Is a Deceased Donor Re-Transplantation Justified?
    Transplantation, vol. 82, no. 8, p. 1112, 2006
  3. Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma
    International Journal of Cancer, vol. 119, no. 12, pp. 2851–2860, 2006
  4. Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report
    Liver Transplantation, vol. 12, no. 6, pp. 934–940, 2006
  5. Liver transplantation for patients with metastatic endocrine tumors: Single-center experience with 15 patients
    Liver Transplantation, vol. 12, no. 7, pp. 1089–1096, 2006
  6. Surgery for Hepatocellular Carcinoma Arising in Hereditary Hemochromatosis
    European Surgical Research, vol. 38, no. 4, pp. 371–376, 2006
  7. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial
    Langenbeck's Archives of Surgery, vol. 390, no. 2, pp. 114–120, 2005
  8. Liver Transplantation for Small Solitary Cholangiocellular Carcinoma in Cirrhosis: A Medical Mistake or a New Indication?
    Transplantation, vol. 80, no. 9, p. 1356, 2005
  9. Neue Techniken in der Lebertransplantation
    Praxis, vol. 94, no. 18, pp. 735–741, 2005
  10. Impact of p53-based immunization on primary chemically-induced tumors
    International Journal of Cancer, vol. 113, no. 6, pp. 961–970, 2004
  11. Lebertransplantation und Lebendspende bei Tumoren
    Viszeralchirurgie, vol. 39, no. 2, pp. 109–113, 2004
  12. Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression
    Cancer Research, vol. 64, no. 17, pp. 6058–6064, 2004
  13. Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets
    Clinical Cancer Research, vol. 10, no. 21, pp. 7260–7269, 2004
  14. Major bile duct injuries after laparoscopic cholecystectomy: a tertiary center experience
    Journal of Gastrointestinal Surgery, vol. 8, no. 6, pp. 679–685, 2004
  15. Future directions in immunosuppression
    Transplantation Proceedings, vol. 36, no. 2, pp. S574–S576, 2004
  16. Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study*1
    Transplantation Proceedings, vol. 36, no. 5, pp. 1489–1491, 2004
  17. Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: Preliminary results of an open prospective study
    Transplantation Proceedings, vol. 36, no. 9, pp. 2671–2674, 2004
  18. Management of chronic hepatitis B in the liver transplant setting
    Transplantation Reviews, vol. 18, no. 4, pp. 171–182, 2004
  19. Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection
    Transplantation Proceedings, vol. 35, no. 6, pp. 2080–2081, 2003
  20. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation
    Clinical Transplantation, vol. 17, no. 6, pp. 554–559, 2003
  21. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape
    Immunology, vol. 109, no. 4, pp. 487–495, 2003
  22. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?
    Reviews in Medical Virology, vol. 12, no. 5, pp. 297–319, 2002
  23. Reduction in the Circulating pDC1/pDC2 Ratio and Impaired Function of Ex Vivo-Generated DC1 In Chronic Hepatitis B Infection
    Clinical Immunology, vol. 104, no. 2, pp. 138–150, 2002
  24. Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe
    European Journal of Clinical Pharmacology, vol. 50, no. 6, pp. 511–512, 1996